Clinical Trials Directory

Trials / Completed

CompletedNCT02122874

Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Hospital General Universitario Elche · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Percutaneous neurostimulation of dermatome T7 increases Insulin segregation by the apancreas and improves glycemic profile in diabetic patients

Conditions

Interventions

TypeNameDescription
DEVICEPercutaneous Neurostimulation (PENS) of dermatome T7The patients undergo PENS of dermatome T7 and follow a 1200 Kcal diet
OTHER1200 Kcal diet

Timeline

Start date
2013-01-01
Primary completion
2014-04-01
Completion
2014-04-01
First posted
2014-04-25
Last updated
2014-04-25

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02122874. Inclusion in this directory is not an endorsement.

Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients (NCT02122874) · Clinical Trials Directory